Cyclophosphamide for anticancer therapy-induced interstitial lung disease in the modern era: a retrospective cohort study

BackgroundDrug-induced interstitial lung disease (DIILD) is a serious complication of cancer treatment that is primarily treated with corticosteroids. However, effective standardized regimens for corticosteroid-refractory DIILD have not been established. Cyclophosphamide (CPA) is an immunosuppressan...

詳細記述

書誌詳細

出版年:	Frontiers in Oncology
主要な著者:	Honami Katahara, Kaede Baba, Hiromichi Nakajima, Chikako Funasaka, Chihiro Kondoh, Yoichi Naito, Hibiki Udagawa, Kohei Shitara, Tomoaki Sasaki, Toshikatsu Kawasaki, Toru Mukohara
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-05-01
主題:	drug-induced interstitial lung disease cyclophosphamide corticosteroid-refractory immune-related pneumonitis immunosuppressant
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1567317/full